New Risk • May 06
New major risk - Revenue and earnings growth Earnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€38.7m market cap, or US$45.6m). New Risk • Apr 13
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (€38.8m market cap, or US$45.5m). Tillkännagivande • Feb 20
Biokarpet S.A., Annual General Meeting, May 27, 2026 Biokarpet S.A., Annual General Meeting, May 27, 2026. Upcoming Dividend • Aug 18
Upcoming dividend of €0.02 per share Eligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%). New Risk • Jul 14
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 5.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (5.7% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€43.4m market cap, or US$50.7m). New Risk • Jun 02
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 312% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.8x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€40.9m market cap, or US$46.4m). New Risk • May 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 2.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€41.7m market cap, or US$47.1m). New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€37.1m market cap, or US$42.2m). New Risk • Mar 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 4.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (4.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€41.5m market cap, or US$43.0m). Tillkännagivande • Feb 19
Biokarpet S.A., Annual General Meeting, Jun 18, 2025 Biokarpet S.A., Annual General Meeting, Jun 18, 2025. Tillkännagivande • Dec 25
Biokarpet S.A.(ATSE:BIOKA) dropped from ATHEX Composite Index Biokarpet S.A. has been dropped from the ATHEX Composite Index. New Risk • Oct 07
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€39.1m market cap, or US$42.9m). New Risk • Sep 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 6.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Share price has been highly volatile over the past 3 months (6.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€44.6m market cap, or US$49.8m). Tillkännagivande • Sep 01
Biokarpet S.A. to Report First Half, 2024 Results on Sep 27, 2024 Biokarpet S.A. announced that they will report first half, 2024 results on Sep 27, 2024 Upcoming Dividend • Aug 19
Upcoming dividend of €0.02 per share Eligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%. New Risk • Aug 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Significant insider selling over the past 3 months (€644k sold). Market cap is less than US$100m (€47.3m market cap, or US$52.1m). New Risk • Apr 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€69.6m market cap, or US$73.9m). Tillkännagivande • Apr 01
Biokarpet S.A. to Report Q4, 2023 Results on Apr 30, 2024 Biokarpet S.A. announced that they will report Q4, 2023 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Nov 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €2.67, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 10x in the Metals and Mining industry in Europe. Total returns to shareholders of 265% over the past three years. Reported Earnings • Oct 05
First half 2023 earnings released: EPS: €0.091 (vs €0.29 in 1H 2022) First half 2023 results: EPS: €0.091 (down from €0.29 in 1H 2022). Revenue: €118.3m (down 10.0% from 1H 2022). Net income: €2.18m (down 69% from 1H 2022). Profit margin: 1.8% (down from 5.3% in 1H 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth. New Risk • Oct 01
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€53.0m market cap, or US$56.0m). Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €2.21, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 8x in the Metals and Mining industry in Greece. Total returns to shareholders of 252% over the past three years. Board Change • Sep 26
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Tillkännagivande • Sep 01
Biokarpet S.A. to Report First Half, 2023 Results on Sep 29, 2023 Biokarpet S.A. announced that they will report first half, 2023 results on Sep 29, 2023 Upcoming Dividend • Aug 21
Inaugural dividend of €0.015 per share Eligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%. Tillkännagivande • Jun 01
Biokarpet S.A., Annual General Meeting, Jun 21, 2023 Biokarpet S.A., Annual General Meeting, Jun 21, 2023, at 11:00 E. Europe Standard Time. Location: LARISA, 5th KLM LARISA-ATHENS Athens Greece Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €2.08, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 285% over the past three years. Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €1.94, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 55% over the past three years. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Sep 30
First half 2022 earnings released: EPS: €0.29 (vs €0.072 in 1H 2021) First half 2022 results: EPS: €0.29 (up from €0.072 in 1H 2021). Revenue: €131.5m (up 46% from 1H 2021). Net income: €6.98m (up 305% from 1H 2021). Profit margin: 5.3% (up from 1.9% in 1H 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 15
Investor sentiment improved over the past week After last week's 17% share price gain to €1.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 86% over the past three years. Tillkännagivande • Sep 02
Biokarpet S.A. to Report First Half, 2022 Results on Sep 28, 2022 Biokarpet S.A. announced that they will report first half, 2022 results on Sep 28, 2022 Tillkännagivande • Jun 01
Biokarpet S.A., Annual General Meeting, Jun 22, 2022 Biokarpet S.A., Annual General Meeting, Jun 22, 2022, at 09:00 Coordinated Universal Time. Location: LARISA, 5th KLM LARISSA-ATHENS Athens Greece Reported Earnings • May 05
Full year 2021 earnings released: EPS: €0.17 (vs €0.009 in FY 2020) Full year 2021 results: EPS: €0.17 (up from €0.009 in FY 2020). Revenue: €187.3m (up 52% from FY 2020). Net income: €4.21m (up €3.99m from FY 2020). Profit margin: 2.2% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Tillkännagivande • Apr 01
Biokarpet S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022 Biokarpet S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022 Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment deteriorated over the past week After last week's 18% share price decline to €1.35, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 135% over the past three years. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment improved over the past week After last week's 22% share price gain to €1.81, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 174% over the past three years. Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment improved over the past week After last week's 15% share price gain to €1.67, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 209% over the past three years. Reported Earnings • Oct 01
First half 2021 earnings released: EPS €0.072 (vs €0.10 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €90.1m (up 55% from 1H 2020). Net income: €1.72m (up €4.13m from 1H 2020). Profit margin: 1.9% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 28
Full year 2020 earnings released: EPS €0.009 (vs €0.052 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €123.2m (down 2.0% from FY 2019). Net income: €218.8k (down 82% from FY 2019). Profit margin: 0.2% (down from 1.0% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Is New 90 Day High Low • Dec 07
New 90-day high: €0.81 The company is up 19% from its price of €0.68 on 08 September 2020. The Greek market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Metals and Mining industry, which is up 33% over the same period. Is New 90 Day High Low • Oct 27
New 90-day high: €0.76 The company is up 26% from its price of €0.60 on 29 July 2020. The Greek market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 5.0% over the same period. Reported Earnings • Oct 04
First half earnings released Over the last 12 months the company has reported total losses of €1.83m, with earnings decreasing by €3.50m from the prior year. Total revenue was €115.7m over the last 12 months, down 9.6% from the prior year. Tillkännagivande • Sep 06
Biokarpet S.A. to Report First Half, 2020 Results on Sep 30, 2020 Biokarpet S.A. announced that they will report first half, 2020 results on Sep 30, 2020